Although MYC and CDK1 were prioritized based on their consistent upregulation and well-established roles in glioma biology, it is likely that EGR3 governs a wider transcriptional network influencing multiple aspects of tumor progression. This evidence concerns the gene MYC and central nervous system cancer.